Evidence map›Paper›PMID 39438490›Full record

ArticleScientific reports2024

Two-year cumulative live-birth rates and maximum number of transfer cycles in women aged ≥ 40 years.

Sakiko Nukaga, Mikiko Tokoro, Emiko Asano, Daichi Inoue, Yoshiki Hashiba, Noritaka Fukunaga, Yoshimasa Asada

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sakiko NukagaDepartment of Obstetrics and Gynecology, Asada Ladies Clinic, Nagoya, Japan. s_nukaga@ivf-asada.jp.ORCID http://orcid.org/0000-0002-5537-9439
Mikiko TokoroAsada Institute for Reproductive Medicine, Kasugai, Japan.
Emiko AsanoDepartment of Obstetrics and Gynecology, Asada Ladies Clinic, Nagoya, Japan.
Daichi InoueDepartment of Obstetrics and Gynecology, Asada Ladies Clinic, Nagoya, Japan.
Yoshiki HashibaDepartment of Obstetrics and Gynecology, Asada Ladies Clinic, Nagoya, Japan.
Noritaka FukunagaDepartment of Obstetrics and Gynecology, Asada Ladies Clinic, Nagoya, Japan.
Yoshimasa AsadaDepartment of Obstetrics and Gynecology, Asada Ladies Clinic, Nagoya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This retrospective study aimed to clarify the cumulative live-birth rates (CLBRs) and cost per live-birth (LB) to evaluate the validity of frozen-thawed embryo transfer without preimplantation genetic testing for aneuploidy (PGT-A) in women aged ≥ 40 years. The study included 1,011 patients aged ≥ 40 years who underwent their first oocyte retrieval at our hospital between January 2010 and September 2017. They were followed up for up to two years or until either treatment discontinuation or a pregnancy that resulted in a live birth. The 2-year CLBRs were 55.6%, 39.0%, 31.3%, 19.1%, 10.6%, 4.4%, and 0% for patients aged 40, 41, 42, 43, 44, 45, and > 46 years, respectively. In approximately 80% of LB cases, patients aged 40-42 years and 43-44 years became pregnant by the fourth and second transfers, respectively. Costs per LB were $30,207, $49,034, $66,345, $102,759, and $195,862 for patients aged 40, 41, 42, 43, and 44, respectively. Cost per LB for each number of transfers reached $300,000 and $ 450,000 for the third transfer at 42 and 43 years of age, respectively. For cost-effectiveness, up to two ET cycles are recommended for patients aged 42-43, and none for patients aged ≥ 44 years.

Indexed as

Embryo TransferLive BirthAdultAneuploidyBirth RateCryopreservationFemaleFertilization in VitroHumansMiddle AgedOocyte RetrievalPregnancyPregnancy RateRetrospective Studies

Identifiers

PMID39438490
PMCPMC11496526

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.